Real World Observational Study of Sotatercept for Pulmonary Hypertension
Recruiting
Observational Study
Pulmonary Hypertension
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 120 (estimated)
- Sponsor
- Mayo Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study seeks to describe the real world initial experience with sotatercept in the treatment of pulmonary hypertension.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults age 18 or greater who are being treated with sotatercept in the Mayo Pulmonary hypertension clinic.
Exclusion Criteria:
* Adults lacking capacity to consent
Contacts
Louise Durst, R.N.
507-284-1838
CONTACT